The activation of genes such as VEGFA and VEGFR1 under hypoxic conditions underscores the potential of HIF1α and VEGF as biomarkers for aggressive cancer phenotypes, indicating tumor aggressiveness and metastatic potential, which is valuable for prognosis and treatment planning (25, 40–42). The gene discussed is VEGFA; the disease is cancer.